Trilogy Equity Partners Updates Owlet Stake

TL;DR

Trilogy Equity Partners filed an amendment to their Owlet stake. Keep an eye on this.

AI Summary

Trilogy Equity Partners, LLC, through an amendment filed on August 22, 2024, has updated its Schedule 13D regarding Owlet, Inc. The filing indicates a change in beneficial ownership as of August 20, 2024. Trilogy Equity Partners, LLC is based in Bellevue, WA.

Why It Matters

This filing signals a potential shift in significant ownership for Owlet, Inc., which could influence the company's strategic direction and stock performance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can lead to volatility.

Key Players & Entities

• Trilogy Equity Partners, LLC (company) — Filing entity
• Owlet, Inc. (company) — Subject company
• Amy McCullough (person) — Person authorized to receive notices
• August 20, 2024 (date) — Date as of change
• August 22, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.0001 — suer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti
• $4 — 023 Warrant), with an exercise price of $4.662, purchased by the Reporting Person
• $7 — 024 Warrant), with an exercise price of $7.7125, purchased by the Reporting Person

Filing Documents

• d825092dsc13da.htm (SC 13D/A) — 37KB
• 0001193125-24-205381.txt ( ) — 39KB

is amended and replaced in its entirety as follows

Item 5 is amended and replaced in its entirety as follows: (a) Trilogy Equity Partners, LLC, a Delaware limited liability company (the Reporting Person) beneficially owns 2,493,225 shares of Common Stock, or approximately 18.7% of the outstanding Common Stock. This percentage is based on the assumption of (i) 11,710,310 shares of Common Stock outstanding as of August 20, 2024, as reported in the Issuers Current Report on Form 8-K filed with the SEC on August 22, 2024, (ii) 158,309 shares of Common Stock issuable upon the conversion of Series A Convertible Preferred Stock purchased by the Reporting Person pursuant to the 2023 Investment Agreement, (iii) 712,915 shares of Common Stock issuable upon the exercise of the 2023 Warrant purchased by the Reporting Person pursuant to the 2023 Investment Agreement and the 2023 Warrant, (iv) 296,401 shares of Common Stock issuable upon the conversion of Series B Convertible Preferred Stock purchased by the Reporting Person pursuant to the 2024 Investment Agreement, and (v) 444,601 shares of Common Stock issuable upon the exercise of the 2024 Warrant purchased by the Reporting Person pursuant to the 2024 Investment Agreement and the 2024 Warrant. (b) The Reporting Person, has the sole power to vote and dispose, or direct the voting or disposition, of all shares of the Common Stock held by it. (c) On August 20, 2024, the Reporting Person converted 1,631 shares of Series A Convertible Preferred Stock purchased pursuant to the 2023 Investment Agreement at an exchange ratio of 145.7726. The 1,631 shares of Series A Convertible Preferred Stock converted into the right to receive, in the aggregate, 237,755 shares of Common Stock, rounded down to the nearest whole share. (d) Not applicable. (e) Not applicable. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 22, 2024 TRILOGY EQUITY P

View Full Filing

View this SC 13D/A filing on SEC EDGAR